Cone Rod Dystrophy: Clinical Trials

1 trial for Cone Rod Dystrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1
Phase 21Active not recruiting 1

Follow Cone Rod Dystrophy: new trials by email Literature Review of Cone Rod Dystrophy trials Research Report on Cone Rod Dystrophy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
ACDN-01 - Stargardt Disease, Cone Rod Dystrophy
Phase 1 / Phase 2Active not recruitingAscidian Therapeutics, Inc152024-06-112026-11-10

Narrower conditions

Cone-Rod Dystrophies (1)  ·  Stargardt Disease (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Eye Diseases (1)  ·  Eye Diseases, Hereditary (1)  ·  Genetic Diseases, Inborn (1)  ·  Macular Degeneration (1)  ·  Retinal Degeneration (1)  ·  Retinal Diseases (1)  ·  Retinal Dystrophies (1)

Sponsors

Ascidian Therapeutics, Inc (1)

Countries

United States (1)

Top investigators

Murray Abramson, MD, PhD (1)

Results publications

PMID 39281698